- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00993889
Virtual Reality Analgesia During Pediatric Physical Therapy (VRD/Peds)
March 11, 2019 updated by: David R. Patterson, National Institute of General Medical Sciences (NIGMS)
We would like to determine whether Virtual Reality (VR) analgesia continues to be effective for reducing pain when administered for a clinically relevant treatment duration over multiple, repeated exposures (i.e., up to ten sessions of physical therapy per patient).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study is done in a hospital for inpatients pediatrics.
By randomization some subjects will immersive Virtual Reality (VR) during a painful procedure on daily basis up to 10 days to see whether this will reduce the pain and anxiety.
Study Type
Interventional
Enrollment (Actual)
18
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98104-2499
- Harborview Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 20 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age greater than or equal to 8 years up to 20 yrs old
- Compliant and able to complete subject evaluation
- A minimum of 3 days of physical therapy, one physical therapy session per day
- No history of psychiatric (DSM-IV-R Axis I) or developmental disorder that would interfere with decisional capacity
- Not demonstrating delirium, psychosis, or any form of Organic Brain Disorder that would interfere with decisional capacity
- Able to communicate verbally
- Able to take oral medications
- English-speaking
Exclusion Criteria:
- - Age less than 8 years, or greater than 20 years.
- Not capable of indicating pain intensity
- Not capable of filling out study measures
- Hospitalization of fewer than 3 days
- Evidence of traumatic brain injury
- History of psychiatric (DSM-IV-R Axis I) disorder as evidenced in the admitting RN and MD admission notes, if interfering with decisional capacity
- Demonstrating delirium, psychosis or any form of Organic Brain Disorder and associated memory problems that would interfere with decisional capacity
- Unable to communicate verbally
- Unable to take oral medications
- History of sig. cardiac, endocrine, neurologic, metabolic, respiratory, gastrointestinal or genitourinary impairment that would interfere with treatment or decisional capacity
- Receiving prophylaxis for alcohol or drug withdrawal
- Developmental disability that would interfere with decisional capacity
- Face/head/neck injuries preventing helmet use
- Non-English-speaking
- Extreme susceptibility to motion sickness
- Seizure history
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: VR during Physical Therapy
The subject will receive virtual reality during painful physical therapy sessions.
|
Virtual Reality will be performed during a painful physical therapy procedure.
|
|
Experimental: VR background pain
The subjects receives virtual reality, not during a physical therapy procedure, another time of the day for background pain.
|
Virtual Reality is used at anytime during the day for the background pain, not during physical therapy.
|
|
Experimental: No VR
The subject will receive the usual standard treatment.
At the end of the study, before being discharged from the hospital, the subject can experience the VR, not during a procedure.
|
The subject will receive the usual standard treatment.
At the end of the study, before being discharged from the hospital, the subject can experience the VR, not during a procedure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Pain and anxiety
Time Frame: pre and post procedure
|
pre and post procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: David R Patterson, Ph.D., University of Washington
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2009
Primary Completion (Actual)
April 1, 2017
Study Completion (Actual)
April 1, 2017
Study Registration Dates
First Submitted
October 13, 2009
First Submitted That Met QC Criteria
October 13, 2009
First Posted (Estimate)
October 14, 2009
Study Record Updates
Last Update Posted (Actual)
March 13, 2019
Last Update Submitted That Met QC Criteria
March 11, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 36154-C
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Burn
-
Dr Muhammad Naveed ShahzadNot yet recruitingSilver Sulfadiazine With Hyaluronic Acid Versus Silver Sulfadiazine Alone in Partial-Thickness BurnsPartial-Thickness Burn, Thermal BurnPakistan
-
Indonesia UniversityRecruitingBurn Degree Second | Burn Degree ThirdIndonesia
-
Xequel Bio, Inc.United States Department of DefenseWithdrawnThermal Burn | Second Degree Burn
-
Integra LifeSciences CorporationWithdrawnBurn Scar | Burn Injury | Skin Grafting | Burn Wounds - Partial Thickness (2nd Degree)
-
The First Affiliated Hospital of Xinxiang Medical...Not yet recruitingBurn | Burn Degree Second | Burn Contracture of Skin
-
XenoTherapeutics, Inc.Joseph M. Still Research Foundation, Inc.RecruitingWound Heal | Thermal Burn | Burn Degree Second | Burns Degree Third | Burn (Disorder)United States
-
General Electric ResearchTerminatedBurn Wound | 2nd Degree Burn of the SkinUnited States
-
University Hospital, LinkoepingCompletedBurn Scar | Burns | Burn Second DegreeSweden
-
University Hospital Schleswig-HolsteinUniversity of LuebeckRecruitingSecond-degree Burn | Third-Degree BurnGermany
-
Jason SperryUnited States Department of DefenseNot yet recruitingBurn Injury | Thermal BurnUnited States
Clinical Trials on VR during Physical Therapy
-
Klinik für Kardiologie, Pneumologie und AngiologieCompletedPain | Anxiety | Severe Aortic Valve StenosisGermany
-
Riphah International UniversityCompleted
-
Gaziantep City HospitalCompleted
-
University of UtahBelmont University; Benchmark Physical TherapyCompleted
-
Cairo UniversityRecruitingRotator Cuff Injuries | Rotator Cuff Tears | Rotator Cuff Impingement SyndromeEgypt
-
New Jersey Institute of TechnologyKessler Foundation; Rutgers University; Northeastern UniversityCompletedStroke, AcuteUnited States
-
Istinye UniversityRecruitingStroke | Hemiplegia | Upper Extremity DysfunctionTurkey (Türkiye)
-
Shanghai Mental Health CenterNanjing XR-Oasis Technology Co., Ltd.RecruitingBipolar Disorder | Interventional Study | VRChina
-
Superior UniversityActive, not recruiting
-
Thomas More University of Applied SciencesRevalidatieziekenhuis RevArte; To Walk Again REVAlution CenterCompleted